Podcast Appearances: 

The Lady Doc Podcast

Live Like a Mother Podcast

Dr. Teplinsky in the News: 

Actress opens up about fighting stage 3 breast cancer at age 19

‘Knowledge gap’ hinders efforts to improve care of LGBTQ+ patients

The Valley Hospital Explains How Women Can Decrease Breast Cancer Risk

Good News for Older Women With Early Breast Cancer

Drug Duo May Rapidly Shrink Breast Tumors in Some

Aromatase Inhibitors Reduce Contralateral Breast Cancer

Published Blogs/Articles:

Guest Blog for InCrowd: Changing the Practice of Medicine through Storytelling

My Blogs on OncoTherapy Network

Antibody-Drug Conjugates and T-DM1

Published Research Articles:

Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer

A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.

The efficacy of trabectedin in treating ovarian cancer.

Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Targeting HER2 in ovarian and uterine cancers: challenges and future directions.

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.

HE4: another ‘player’ in the epithelial tumor marker arena?